Attempted suicide through acute poisoning with Nebivolol, a selective β 1-adrenergic antagonist;Akute intoxikation mit dem β1-selektiven beta-rezeptorenblocker Nebivolol in suizidaler absicht

Deutsche Medizinische Wochenschrift

Volumn 124, Issue 42, 1999, Pages 1230-1234

  Heinroth, Konstantin M ^a   Kuhn, C ^b   Walper, R ^b   Busch, I ^b   Winkler, M ^b   Prondzinsky, R ^b  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; CHARCOAL; GLUCAGON; GLUCOSE; INSULIN; NEBIVOLOL; SODIUM SULFATE;

ADOLESCENT; ARTICLE; CARDIOVASCULAR FUNCTION; CASE REPORT; DRUG BLOOD LEVEL; DRUG INTOXICATION; DRUG METABOLISM; EMERGENCY TREATMENT; FATALITY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTRAVENOUS DRUG ADMINISTRATION; NEUROLOGIC EXAMINATION; PACEMAKER; STOMACH LAVAGE; SUICIDE ATTEMPT;

EID: 0033595741     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1024525     Document Type: Article

References (14)

1. Benjamin, S., P. D. Mueller, J. L. Falk: General management of the poisoned patient. J. Fla. Med. Assoc. 84 (1997), 557-560.
2. Cockcroft, J. R., P. J. Chowienczyk, S. E. Brett, C. P. Chen, A. G. Dupont, L. Van Nueten, et al.: Nebivolol vasodilates human forearm vasculature: evidence for an L-arginine/NO-dependent mechanism. J. Pharmacol. Exp. Ther. 274 (1995), 1067-1071.
3. Fogari, R., A. Zoppi, P. Lazzari, A. Mugellini, P. Lusardi, P. Preti, et al.: Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetes. J. Hum. Hypertens. 11 (1997), 753-757.
4. Gao, Y. S., T. Nagao, R. A. Bond, W. J. Janssens, P. M. Vanhoutte: Nebivolol induces endothelium-dependent relaxations of canine coronary arteries. J. Cardiovasc. Pharmacol. 17 (1991), 964-969.
5. Janssens, W., A. Van-de Water, R. Xhonneux, R. S. Reneman, L. Van Nueten, P. A. Janssen: Nebivolol is devoid of intrinsic sympathomimetic activity. Eur. J. Pharmacol. 159 (1989), 89-95.
6. Kerns, W., D. Schroeder, C. Williams, C. Tomaszewski, R. Raymond: Insulin improves survival in a canine model of acute beta-blocker toxicity. Ann. Emerg. Med. 29 (1997), 748-757.
7. Larsen, L. C., D. M. Cummings: Oral poisonings: guidelines for initial evaluation and treatment. Am. Fam. Physician. 57 (1998), 85-92.
8. Love, J. N., T. L. Litovitz, J. M. Howell, C. Clancy: Characterization of fatal beta blocker ingestion: a review of the American Association of Poison Control Centers data from 1985 to 1995. J. Toxicol. Clin, Toxicol. 35 (1997), 353-359.
9. Pertoldi, P., L. D'Orlando, W. P. Mercante: Electromechanical dissociation 48 hours after atenolol overdose: usefulness of calcium chloride. Ann. Emerg. Med. 31 (1998), 777-781.
10. Reithmann, C., K. Werdan: Regulation der beta-Rezeptoren - Praktische Konsequenzen für die Therapie. Internist. Berl. 31 (1990), 625-631.
11. Schmidt, W., M. Nottrott, H. Desel: Lebensbedrohliche akute Intoxikationen dutch kardio- und vasotoxisch wirkende Medikamente. Intensiv- und Notfallbehandlung 1 (1998), 27-49.
12. Taboulet, P.: Intoxications aigues par les beta-bloquants et par les inhibiteurs calciques. Rev. Prat. 47 (1997), 742-747.
13. Vale, J. A.: Position statement: gastric lavage. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J. Toxicol. Clin. Toxicol. 35 (1997), 711-719.
14. Van-de Water, A., W. Janssens, J. Van Neuten, R. Xhonneux, J. De Cree, H. Verhaegen, et al.: Pharmacological and hemodynamic profile of nebivolol, a chemically novel, potent, and selective beta 1-adrenergic antagonist. J. Cardiovasc. Pharmacol. 11 (1988), 552-563.